Cleared Traditional

SCEPTOR - NEW ANTIMICROBIAL AGENT: RIFAMPIN (K882909) - FDA 510(k) Clearance

Class II Microbiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K882909 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1988
Decision
48d
Days
Class 2
Risk

K882909 is an FDA 510(k) clearance for the SCEPTOR - NEW ANTIMICROBIAL AGENT: RIFAMPIN. Classified as Manual Antimicrobial Susceptibility Test Systems (product code JWY), Class II - Special Controls.

Submitted by Bd Becton Dickinson Vacutainer Systems Preanalytic (Franklin Lakes, US). The FDA issued a Cleared decision on August 29, 1988 after a review of 48 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.1640 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bd Becton Dickinson Vacutainer Systems Preanalytic devices

Submission Details

510(k) Number K882909 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 12, 1988
Decision Date August 29, 1988
Days to Decision 48 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
54d faster than avg
Panel avg: 102d · This submission: 48d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JWY Manual Antimicrobial Susceptibility Test Systems
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.1640
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - JWY Manual Antimicrobial Susceptibility Test Systems

All 121
Devices cleared under the same product code (JWY) and FDA review panel - the closest regulatory comparables to K882909.
SCEPTOR RESISTANT GRAM-NEGATIVE MIC/ID #80332
K883555 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Sep 1988
GRAM NEGATIVE & GRAM POSITIVE MIC/COMBO PANELS
K883076 · Baxter Healthcare Corp · Sep 1988
GRAM NEGATIVE AND GRAM POSITIVE MIC/COMBO PANELS
K883394 · Baxter Healthcare Corp · Sep 1988
SCEPTOR NEW ANTIMICROBIAL AGENT: AMPICILLIN/SULBAC
K882910 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Aug 1988
SCEPTOR EXTEN. OF CONCENTRATION RANGE: PENCILLIN
K882911 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Aug 1988
SCEPTOR NEW ANTIMICROBIAL AGENT: IMIPENEM
K882912 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Aug 1988